Skip to the main content.

Product Details
BOND® Training Information
Prescribing Information
FAQ
Behavior Bits
Get In Touch

Product Details
BOND® Training Information
Prescribing Information
FAQ
Behavior Bits
Get In Touch

All Behavior Bits

Video June 16, 2021

Veterinary Visit Expectations

Hear more about what to expect if you are bringing your pet in for anxiety-related behavior concerns.

All Behavior Bits

IMPORTANT SAFETY INFORMATION: The most common adverse events reported in decreasing order of reported frequency are: decreased appetite, depression/lethargy, shaking/shivering/tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, mydriasis, vocalization, weight loss, panting, confusion, incoordination, and hypersalivation. Reconcile chewable tablets are contraindicated for dogs with a history of seizures or when used with MAOIs. For product label, including complete safety information, see package insert.

NADA#141-272

The information, tools and material presented on this site are provided for informational and educational purposes only. Please consult your veterinarian for an official diagnosis of canine separation anxiety and to learn more about Reconcile. Click here to read the complete terms and conditions regarding use of this website.

Terms Of Use

© 2026 PRN Pharmacal, Inc. All rights reserved.

PRN® and Reconcile® are registered trademarks of Pegasus Laboratories, Inc.